← All trials
NCT04395196
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2021
- Primary completion
- Feb 1, 2026
- Completion date
- Feb 1, 2026
- First posted
- May 20, 2020
- Last posted
- May 22, 2020
- Enrollment
- 288
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Wayne State UniversityLead sponsor
- Wayne State UniversityReponsible party - principal investigator
- Columbia UniversityCollaborator
- University of Cape TownCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.